The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with ...

A spokesperson for Novo Nordisk, the manufacturer of Wegovy, said: “Wegovy is indicated for weight management, including ...

A cardiologist's assertion that Ozempic is a \"cardiometabolic medicine\" rather than just a weight-loss trend has sparked ...